Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1.

@article{Evering2007RaltegravirA,
  title={Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1.},
  author={Teresa Hope Evering and Martin Markowitz},
  journal={Drugs of today},
  year={2007},
  volume={43 12},
  pages={865-77}
}
In the developed world, access to highly active antiretroviral therapy (HAART) has led to significant reductions in the morbidity and mortality attributed to HIV/AIDS. However, the continual emergence of HIV-1 strains resistant to currently available classes of antiretrovirals highlights the need to develop agents with novel mechanisms of action. Successful completion of the HIV-1 viral life cycle depends in part on the integration of complementary DNA mediated by the enzyme HIV-1 integrase… CONTINUE READING
21 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 21 extracted citations

Similar Papers

Loading similar papers…